S
Scientific and Medical Equipment House Company CJSC
SAU:4014
Scientific and Medical Equipment House Company CJSC
SAU:4014
Price:
49.7 SAR
-5.51%
Market Closed
Updated:
May 15, 2024
Income Statement
Earnings Waterfall
Scientific and Medical Equipment House Company CJSC
Scientific and Medical Equipment House Company CJSC
|
Revenue
|
799.3m
SAR
|
|
Cost of Revenue
|
-666.2m
SAR
|
|
Gross Profit
|
133.1m
SAR
|
|
Operating Expenses
|
-64.1m
SAR
|
|
Operating Income
|
69m
SAR
|
|
Other Expenses
|
-28.9m
SAR
|
|
Net Income
|
40.1m
SAR
|
Income Statement
Scientific and Medical Equipment House Company CJSC
Scientific and Medical Equipment House Company CJSC
Currency: SAR
| Jun-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue |
779
N/A
|
0
N/A
|
845
N/A
|
704
-17%
|
890
+26%
|
714
-20%
|
716
+0%
|
731
+2%
|
756
+4%
|
799
+6%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(600)
|
(546)
|
(654)
|
(542)
|
(692)
|
(559)
|
(568)
|
(600)
|
(625)
|
(666)
|
|
| Gross Profit |
179
N/A
|
153
-15%
|
192
+25%
|
162
-15%
|
198
+22%
|
155
-22%
|
148
-5%
|
131
-11%
|
132
+1%
|
133
+1%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(74)
|
(69)
|
(87)
|
(81)
|
(102)
|
(117)
|
(120)
|
(117)
|
(109)
|
(64)
|
|
| Selling, General & Administrative |
(74)
|
(65)
|
(87)
|
(81)
|
(102)
|
(108)
|
(120)
|
(117)
|
(109)
|
(55)
|
|
| Depreciation & Amortization |
0
|
(5)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(9)
|
|
| Operating Income |
105
N/A
|
0
-100%
|
105
+30 341%
|
81
-23%
|
97
+20%
|
38
-61%
|
28
-26%
|
14
-50%
|
23
+64%
|
69
+199%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(16)
|
(14)
|
(18)
|
(18)
|
(23)
|
(20)
|
(22)
|
(22)
|
(23)
|
(26)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Total Other Income |
17
|
98
|
18
|
14
|
16
|
10
|
10
|
9
|
9
|
10
|
|
| Pre-Tax Income |
106
N/A
|
85
-20%
|
106
+24%
|
77
-27%
|
90
+16%
|
28
-69%
|
17
-40%
|
1
-94%
|
9
+845%
|
53
+507%
|
|
| Net Income | |||||||||||
| Tax Provision |
(13)
|
(8)
|
(12)
|
(10)
|
(14)
|
(12)
|
(11)
|
(11)
|
(10)
|
(15)
|
|
| Income from Continuing Operations |
93
|
77
|
94
|
68
|
76
|
16
|
5
|
(10)
|
(1)
|
38
|
|
| Income to Minority Interest |
2
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
2
|
2
|
|
| Net Income (Common) |
95
N/A
|
78
-18%
|
94
+22%
|
69
-27%
|
77
+13%
|
18
-77%
|
8
-56%
|
(8)
N/A
|
1
N/A
|
40
+3 343%
|
|
| EPS (Diluted) |
4.74
N/A
|
2.58
-46%
|
4.71
+83%
|
3.43
-27%
|
3.86
+13%
|
0.59
-85%
|
0.25
-58%
|
-0.25
N/A
|
0.04
N/A
|
1.34
+3 250%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
